Noninvasive prenatal testing for aneuploidy–ready for prime time? - 30/03/12
Doi : 10.1016/j.ajog.2012.02.021
Lyn S. Chitty, MRCOG a, Melissa Hill, PhD a, b, Helen White, PhD d, David Wright, PhD e, Stephen Morris, PhD c
a Clinical and Molecular Genetics Unit, University College London Institute of Child Health, London, United Kingdom
b Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom
c Center of Applied Health Research, Research Department of Epidemiology and Public Health, University College London, London, United Kingdom
d National Genetics Reference Laboratory, Salisbury District Hospital, Salisbury, United Kingdom
e School of Computing and Mathematics, University of Plymouth, Plymouth, United Kingdom
Le texte complet de cet article est disponible en PDF.
Plan
| L.S.C., M.H., H.W., and S.M. are part of the RAPID Team, which is funded by the National Institute for Health Research (NIHR) Program Grants for Applied Research (RP-PG-0707-10107). L.S.C. and S.M. are partially funded by the NIHR Biomedical Research Center at University College National Health Service Foundation Trust and University College London. L.S.C. receives support from the Great Ormond Street Hospital Children's Charity. The views expressed in this article are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health. |
|
| Reprints not available from the authors. |
© 2012
Publié par Elsevier Masson SAS.
Vol 206 - N° 4
P. 269-275 - avril 2012 Retour au numéro
Article précédent
- Information for readers
- The natural history of pelvic vein thrombosis: the natural history of involution?
- Andra H. James
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?